AMY BAIRD: Open Payments
NPI 1073697546 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 80 payments from 24 companies in 2025. Trend: 2023 $1,322 · 2024 $1,127 · 2025 $1,544
Food & beverage: $1,544
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 11 | $240 |
| Novo Nordisk Inc | 14 | $232 |
| Abbott Laboratories | 12 | $175 |
| Tandem Diabetes Care, Inc. | 3 | $104 |
| Sequel Med Tech, LLC | 3 | $89 |
| Amgen Inc. | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $61 |
| Corcept Therapeutics | 3 | $59 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $56 |
Products named: Omnipod, FREESTYLE LIBRE 3, Ozempic, t:slim X2 Insulin Pump with Control-IQ, TWIIST, Wegovy, Korlym, ISTURISA.
Industry payments across KY — which companies pay providers there.
